Prostatic Neoplasms: all 6,484 studies
Page 32 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate CancerStatus unknownNCT05246774
- Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate CancerWithdrawnNCT05245435Not applicable
- PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate CancerActive, not recruitingNCT05245006Phase 1
- A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate CancerTerminatedNCT05241613Phase 1
- MiProstate - Information Hub for the Prostate Cancer Care FlowCompletedNCT05239377
- SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
- Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in MartiniqueCompletedNCT05231915Not applicable
- Radioligand fOr locAl raDiorecurrent proStaTe cancERCompletedNCT05230251Phase 1/2
- Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.Active, not recruitingNCT05228197
- Video Education With Result Dependent dIsclosureCompletedNCT05225428Not applicable
- Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate CancerTerminatedNCT05224869Not applicable
- Retzius-sparing Technique in Robotic-assisted Radical ProstatectomyStatus unknownNCT05224024Not applicable
- Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST TrialActive, not recruitingNCT05223582Phase 2
- Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate CancerStatus unknownNCT05212857Phase 2
- The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)TerminatedNCT05208229
- 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT05204927Phase 3
- Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer PatientsCompletedNCT05202340
- A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication CompletelyCompletedNCT05202301
- Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part IIBCompletedNCT05200039
- Validity, Reliability and Minimum Detectable Changes of 2-Minute Walk , Timed Up and Go, Sit and Stand Test in Patients With Prostate CancerCompletedNCT05195190
- Evaluation of Fapi-pet in Prostate Cancer.Status unknownNCT05192694Not applicable
- Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPCWithdrawnNCT05191017Phase 1/2
- First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate CancerActive, not recruitingNCT05189457Phase 2
- Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA TrialStatus unknownNCT05188911
- Promoting Shared-decision Making in Opportunistic Screening for Prostate CancerStatus unknownNCT05187949
- Electrical Patient Reported Outcome of Prostate Cancer RadioTherapyStatus unknownNCT05187026
- A Study to Assess Mitomic Prostate Test for Prostate Cancer ScreeningStatus unknownNCT05180305
- The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate BiopsyStatus unknownNCT05179720Not applicable
- A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate CancerStatus unknownNCT05179707
- The TRANSLATE TrialStatus unknownNCT05179694Not applicable
- RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)CompletedNCT05176756Not applicable
- Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate CancerCompletedNCT05171387Phase 2
- A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate CancerActive, not recruitingNCT05169970Phase 2
- Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From BrazilTerminatedNCT05169372
- Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT05168618Phase 2
- The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene MutationStatus unknownNCT05167175Phase 2
- EBRT + Lu-PSMA for N1M0 Prostate CancerCompletedNCT05162573Phase 1
- Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive BiopsyActive, not recruitingNCT05160597Early Phase 1
- A Study of PRT2527 in Participants With Advanced Solid TumorsCompletedNCT05159518Phase 1
- Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate CancerTerminatedNCT05156905Phase 1
- TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate CancerStatus unknownNCT05156450Phase 2
- A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate CancerStatus unknownNCT05156424Phase 1/2
- Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer PatientsWithdrawnNCT05156372Not applicable
- Intervention Study in Prostate Cancer Patients Undergoing RadiotherapyActive, not recruitingNCT05155618Not applicable
- PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRIActive, not recruitingNCT05154162Phase 3
- EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPCActive, not recruitingNCT05150236Phase 2
- A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate CancerCompletedNCT05149131
- External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)CompletedNCT05146973Phase 2
- Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsCompletedNCT05146297Not applicable
- 18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer PatientsCompletedNCT05141760Phase 2
- Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)CompletedNCT05141383Not applicable
- Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®CompletedNCT05140512Phase 1
- Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided Prostate Biopsy (PROBIOP)CompletedNCT05137561Phase 2/3
- A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.CompletedNCT05137067Phase 2
- A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the BonesCompletedNCT05133440Phase 2
- The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
- MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate CancerCompletedNCT05127850Not applicable
- IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate CancerTerminatedNCT05124795Phase 1
- PRISMA-PET - Primary Staging of Prostate Cancer With PSMATerminatedNCT05123300Not applicable
- Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.CompletedNCT05120973
- Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in JapanCompletedNCT05114746Phase 2
- Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder CancerCompletedNCT05109884Not applicable
- A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate CancerActive, not recruitingNCT05100472Phase 2
- Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart StudyCompletedNCT05099679Not applicable
- Pioglitazone and Insulin Resistance in ADTWithdrawnNCT05098327Phase 3
- Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate CancerActive, not recruitingNCT05096338
- Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007CompletedNCT05079828Not applicable
- A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate CancerActive, not recruitingNCT05079698Phase 1
- Optimizing Positive Predicting Value of Prostate MRIStatus unknownNCT05078359
- Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate CancerStatus unknownNCT05078151Not applicable
- Study of ADXS-504 Immunotherapy for Recurrent Prostate CancerCompletedNCT05077098Phase 1
- Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate CancerStatus unknownNCT05076851Phase 2
- EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPCTerminatedNCT05075577Phase 1/2
- A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate CancerStatus unknownNCT05073653Not applicable
- TransPERineal Fusion Biopsy Versus transrECTalCompletedNCT05069584Not applicable
- Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsStatus unknownNCT05068180Phase 4
- Massage for Prostate Cancer-Related Fatigue (mPROSTATE)TerminatedNCT05067777Phase 2
- Targeted Radiotherapy for Recurrent Prostate CancerStatus unknownNCT05067660Not applicable
- A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate CancerActive, not recruitingNCT05067140Phase 1/2
- Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer CenterCompletedNCT05065944
- Exercise as Medicine for People With Cancer SwedenCompletedNCT05064670Not applicable
- Utility of Adding MR Fusion to Standard US Guided Prostate BiopsySuspendedNCT05064111
- Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)Active, not recruitingNCT05056077Not applicable
- Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate CancerActive, not recruitingNCT05055843Not applicable
- Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyActive, not recruitingNCT05053152Phase 2
- 18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.Status unknownNCT05048537Not applicable
- An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate CancerActive, not recruitingNCT05047965Early Phase 1
- Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With HistopathologyWithdrawnNCT05046782Phase 2
- SCAP vs HIFU for Recurrent Prostate Cancer After Radiation TherapyStatus unknownNCT05044754
- A Web-based Peer Navigation Program for Men With Prostate CancerCompletedNCT05041504Not applicable
- Evaluation of Knowledge and Practice About Prostate Cancer in Male EmployeesCompletedNCT05040672
- Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate CancerTerminatedNCT05037500Phase 1
- A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)WithdrawnNCT05035732Not applicable
- Gallium-68 PSMA-11 PET in Participants With Prostate CancerWithdrawnNCT05034562Phase 2
- A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesActive, not recruitingNCT05032040Phase 2
- A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate CancerActive, not recruitingNCT05027477Not applicable
- Ask Questions (ASQ):Implementation of a Communication InterventionCompletedNCT05025748Not applicable
- Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled StudyStatus unknownNCT05025527Not applicable
- A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer ParticipantsCompletedNCT05022849Phase 1
- Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate BiopsyCompletedNCT05022576Not applicable